| AASK |
African American Study
of Kidney Disease and Hypertension |
| ABCD |
Appropriate Blood Pressure
Control in Diabetes Trial |
| ACCORD |
Action to Control Cardiovascular Risk in Diabetes |
| ACTION |
A Coronary Disease Trial
Investigating Outcome with Nifedipine GITS |
| ADVANCE |
Action in Diabetes and
Vascular Disease |
| ALLHAT |
Antihypertensive and
Lipid Lowering Treatment to Prevent Heart Attacks Trial |
| ANBP2 |
Second Australian National
Blood Pressure Study |
| ASCOT |
Anglo-Scandinavian Cardiac
Outcomes Trial |
| BENEDICT |
Bergamo Nephrologic Diabetes
Complication Trial |
| CAMELOT |
Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis |
| CAPPP |
Captopril Prevention
Project |
| CASE J |
Candesartan Antihypertensive Survival Evaluation in Japan |
| CONVINCE
|
Controlled
Onset Verapamil Investigation of Cardiovascular Endpoints Trial |
| COPE
|
Combination Therapy of Hypertension to Prevent Cardiovascular Events |
| DIAB-HYCAR |
Diabetes Hypertension
Cardiovascular Morbidity-Mortality and Ramipril Trial |
| ELSA
|
European
Lacidipine Study on Atherosclerosis |
| EUROPA |
European Trial on Reduction
of Cardiac Events with Perindopril in Ischaemic Heart Disease |
| FEVER |
Felodipine Event Reduction Study |
| HOMED-BP |
Hypertension Objective Treatment based on Measurement by Electrical Devices of Blood Pressure Study |
| HOPE |
Heart Outcomes Prevention
Evaluation Study |
| HOT |
Hypertension Optimal
Treatment Study |
| HYVET |
Hypertension in the Very
Elderly Trial |
| IDNT |
Irbesartan Diabetic Nephropathy
Trial |
| INTEROUT |
Intensified versus Routine Antihypertensive Therapy in High Risk Hypertensive Patients |
| INSIGHT |
International Nifedipine
GITS Study: Intervention as a Goal for Hypertension Therapy |
| INVEST |
International Verapamil-Trandolapril
Study |
| JATOS |
Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients |
| JMIC_B |
Japan Multicenter Investigation for Cardiovascular Diseases (B) |
| LIFE |
Losartan Intervention
for Endpoint Reduction in Hypertension Study |
| MOSES |
Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention |
| NICOLE |
Nisoldipine in Coronary
Artery Disease in Leuven Study |
| NICS-EH |
National Intervention
Cooperative Study in Elderly Hypertensives |
| NORDIL |
Nordic Diltiazem Study |
| ONTARGET |
Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial |
| PART2
|
Prevention
of Atherosclerosis with Ramipril Trial |
| PEACE |
Prevention of Events
with Angiotensin Converting Enzyme Inhibition |
| PREVENT |
Prospective Randomized
Evaluation of the Vascular Effects of Norvasc Trial |
| PROGRESS |
Perindopril Protection
Against Recurrent Stroke Study |
| QUIET
|
Quinapril
Ischaemic Event Trial |
| RENAAL |
Randomized Evaluation
of Non-Insulin-Dependent Diabetes Mellitus with the Angiotensin
II Antagonist Losartan |
| ROADMAP |
Randomized Olmesartan And Diabetes Microalbuminuria Prevention Study |
| SCAT |
Simvastatin/Enalapril
Coronary Atherosclerosis Trial |
| SCOPE |
Study on Cognition and
Prognosis in the Elderly |
| SHELL |
Systolic Hypertension
in the Elderly Long-term Lacidipine Trial |
| STOP-2 |
Swedish Trial in Old
Patients with Hypertension |
| SYST-EUR |
Systolic Hypertension
in Europe Trial |
| TRANSCEND |
Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease |
| UKPDS-HDS |
UK Prospective Diabetes
Study - Hypertension in Diabetes Study |
| VALISH |
Valsartan in Elderly Isolated Systolic Hypertension |
| VHAS |
Verapamil in Hypertension
and Atherosclerosis Study |
